Neuraxis, INC
Develops FDA-cleared, drug-free neuromodulation devices for gut-brain disorders.
NRXS | NYSE
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 11611 N. MERIDIAN ST, 46032 CARMEL
- Website:
- https://neuraxis.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
NeurAxis, Inc. is a medical technology company that develops and commercializes neuromodulation therapies for chronic and debilitating conditions. The company's primary focus is on disorders of gut-brain interactions (DGBIs), such as functional abdominal pain associated with Irritable Bowel Syndrome (IBS) and functional dyspepsia. Its flagship product, IB-Stim, is a first-to-market, FDA-cleared Percutaneous Electrical Nerve Field Stimulation (PENFS) device. This non-surgical, drug-free therapy is designed to treat pain by targeting the gut-brain axis. Originally indicated for pediatric and adolescent patients, NeurAxis is expanding its technology to address the needs of the adult population with gastrointestinal issues.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Neuraxis, INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Neuraxis, INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Neuraxis, INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
